Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
Scientists have identified why some gut microbes successfully stay in the gut after faecal transplants, whilst others are much more transient. They tracked key genetic features of gut bacteria in 86 healthy adults over the course of a year.
Read storyEnteroBiotix announced that the investigator-initiated Phase 2a MAST trial has completed its enrolment of 50 adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT) for defined haematological malignancies.
A new study suggests that exercise stimulates a molecular link between gut bacteria and the brain. The research examined what happens to the gut microbiota, circulating metabolites, and hippocampal gene expression when rats are given free access to a running wheel for eight weeks.
A large-scale evolutionary analysis shows most zoonotic viruses emerge without prior adaptation, while passing through a laboratory leaves detectable genetic signatures, offering a new tool to interpret outbreak origins.
A new study reveals that mixtures of artificial sweeteners can stimulate soil bacteria to release microscopic extracellular vesicles that carry antibiotic resistance genes (ARGs).
Researchers have published a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells.
An antibody test for the infectious disease Mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting.
A new study identifies 80 proteins involved in plasma membrane repair in budding yeast, laying the foundation for membrane repair studies and future therapeutic applications.
Researchers have modified a probiotic yeast to make it safer for use by immunocompromised people, older adults and infants. Testing in an animal model found the modified yeast is less likely to cause infection than unmodified strains of the same organism.
Researchers conducted a prospective cross-sectional study to evaluate cognitive function in patients with pituitary neuroendocrine tumors and examine associations among tumor lineage, hormonal abnormalities, and gut microbiota composition.
A review synthesizes growing evidence showing that commensal microbes enhance anti-tumor immunity by producing immune-active metabolites, remodeling the tumor microenvironment, and activating key immune cells such as dendritic cells and cytotoxic T cells.
The “hygiene hypothesis” suggests exposure to diverse types of microbes may protect against developing diseases caused by allergens, but a new study in mice reveals that adults’ exposure to diverse microbes and allergens may in fact worsen certain allergic conditions.
Researchers studying C. diff at multiple levels, from how individual bacterial cells behave inside the gut to the molecular switches that help them survive and spread, are revealing hidden vulnerabilities.
A new study finds that herpes simplex virus uses a protein called infected cell protein 4 (ICP4) to make the human nucleus more fluid-like, which in turn makes it easier for the virus to replicate itself. Blocking the ability of ICP4 to fluidize the nuclear compartment caused a drop in viral copy production.
What impact does a viral infection have on our memory, attention, and concentration? A new review has identified several biological markers associated with cognitive decline in the context of infection. It also provides a solid foundation for future research.
Researchers have identified fundamental gaps in current mathematical modelling approaches that prevent translation of science into policy, including data limitations, knowledge gaps about AMU-AMR relationships, and the absence of international coordination mechanisms similar to climate change efforts.
Researchers have synthesized and tested a new compound in mice that shows promise in protecting the liver from damage and improving nutrient absorption after small bowel resection. They also found that the drug works only on the gastrointestinal tract.
A proof-of-concept study demonstrates that the harmless eye-dwelling microbe Corynebacterium mastitidis can be genetically modified to secrete an anti-inflammatory therapeutic that promotes healing following corneal injury in a mouse model.
A red extract made from Talaromyces amestolkiae was tested in the bases of potential products, including face cream, shampoo, and gel sticks, for its antioxidant and antibacterial properties.
A new study shows that a low‑protein diet activates a precise set of gut microbes that send chemical signals throughout the body, prompting fat tissue to burn energy instead of storing it. The findings uncover a previously unknown biological pathway linking diet, the gut microbiome and metabolic health.
A new study shows an urgent need for improved detection and treatment of Lassa fever. The study in Liberia found a high prevalence of Lassa fever among febrile admissions: 11% of patients with fever had Lassa fever despite not being suspected clinically.
Researchers report that a gut microbiota–derived metabolite can directly shape immune responses in bacterial pneumonia. Using a Klebsiella pneumoniae infection model, the team demonstrated that butyric acid restores the function of CX3CR1-positive natural killer cells.
Researchers reveal that salivary bacteria from gum disease alter gut metabolism, driving osteoclast activity and systemic bone loss. They analyzed salivary microbiota from individuals with advanced periodontitis and compared them with samples from periodontally healthy donors.